Loomis, Sayles & Company
AGN

Loomis, Sayles & Company’s Allergan plc AGN Stock Holding History

Loomis, Sayles & Company’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-27,314
Closed -$4.57M – 749
2019
Q2 		$4.57M Sell
27,314
-5,914
-18% -$819K 0.01% 420
2019
Q1 		$4.87M Buy
33,228
+4,850
+17% +$703K 0.01% 434
2018
Q4 		$3.79M Sell
28,378
-114,191
-80% -$18.7M 0.01% 439
2018
Q3 		$27.2M Sell
142,569
-123,708
-46% -$22.7M 0.05% 172
2018
Q2 		$44.4M Sell
266,277
-53,044
-17% -$8.52M 0.09% 96
2018
Q1 		$53.7M Buy
319,321
+1,340
+0.4% +$225K 0.11% 83
2017
Q4 		$52M Buy
317,981
+51,935
+20% +$9.32M 0.11% 86
2017
Q3 		$54.5M Buy
266,046
+92,005
+53% +$21.4M 0.12% 89
2017
Q2 		$42.3M Sell
174,041
-33,243
-16% -$7.81M 0.1% 104
2017
Q1 		$49.5M Sell
207,284
-6,297
-3% -$1.47M 0.12% 100
2016
Q4 		$44.9M Sell
213,581
-586,942
-73% -$122M 0.11% 118
2016
Q3 		$184M Buy
800,523
+18,673
+2% +$4.56M 0.47% 36
2016
Q2 		$181M Buy
781,850
+172,364
+28% +$39.7M 0.49% 37
2016
Q1 		$163M Sell
609,486
-3,383
-0.6% -$968K 0.46% 40
2015
Q4 		$192M Buy
612,869
+25,205
+4% +$7.5M 0.54% 37
2015
Q3 		$160M Sell
587,664
-7,286
-1% -$2.24M 0.47% 40
2015
Q2 		$181M Buy
594,950
+52,621
+10% +$15.7M 0.49% 42
2015
Q1 		$161M Buy
542,329
+185,996
+52% +$53M 0.45% 45
2014
Q4 		$91.7M Buy
356,333
+114,837
+48% +$28.7M 0.25% 72
2014
Q3 		$58.3M Buy
+241,496
New +$54M 0.17% 123
2014
Q1 		– Sell
-31,904
Closed -$5.36M – 791
2013
Q4 		$5.36M Buy
31,904
+1,921
+6% +$300K 0.02% 540
2013
Q3 		$4.32M Sell
29,983
-5,337
-15% -$711K 0.01% 547
2013
Q2 		$4.46K Buy
+35,320
New +$4M 0.02% 532

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company's AGN Position: Q3 2019 in Review

Loomis, Sayles & Company sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 27,314 shares — an estimated $4.57M sold.

Loomis, Sayles & Company first reported a position in AGN in Q2 2013 and held it in 23 quarters. The position peaked at $192M in Q4 2015. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Loomis, Sayles & Company reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Loomis, Sayles & Company sold 27,314 Allergan plc shares in Q3 2019, an estimated $4.57M.
  • Loomis, Sayles & Company first reported a position in Allergan plc in Q2 2013 and held it in 23 quarters.
  • Loomis, Sayles & Company's Allergan plc position peaked at $192M in Q4 2015.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Loomis, Sayles & Company's 13F filing for Q3 2019, filed 13 Nov 2019.